NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. - Wikidata - awgldk - TriplyDB

NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells.

NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells.

http://www.wikidata.org/entity/Q43779020

about

Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2 Cell Proliferation in Neuroblastoma Signals from within: the DNA-damage-induced NF-kappaB response NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway Geldanamycin attenuates 3‑nitropropionic acid‑induced apoptosis and JNK activation through the expression of HSP 70 in striatal cells.NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells TAp63 is a transcriptional target of NF-kappaB.Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors.IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma.Regulation of ΔNp63α by NFκΒ Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cells Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase.Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells Orphanin FQ/nociceptin activates nuclear factor kappa B.Signaling from p53 to NF-kappa B determines the chemotherapy responsiveness of neuroblastoma.FK-3000 isolated from Stephania delavayi Diels. inhibits MDA-MB-231 cell proliferation by decreasing NF-κB phosphorylation and COX-2 expression.Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response.The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease.Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB.Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95 Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways Inflammation and cancer: role of nuclear factor-kappaB activation.Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells.Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome.Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer.The diverse and complex roles of NF-κB subunits in cancer.Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells.WDNM1 is associated with differentiation and apoptosis of mammary epithelial cells.Reveromycin A-Induced Apoptosis in Osteoclasts Is Not Accompanied by Necrosis.The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells.Radiation-induced TNFα cross signaling-dependent nuclear import of NFκB favors metastasis in neuroblastoma.Low Dose of Bisphenol A Activates NF-κB/IL-6 Signals to Increase Malignancy of Neuroblastoma Cells.Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines.

P2860

Q24309606-A4764977-BF5C-4DC2-9302-21DBC56659A2 Q26771708-6D2EF912-4FA8-4E55-936F-D7C109465B29 Q28291658-487F51B5-890E-4C65-AFBB-6AE1ED618687 Q28304255-BD6C32D6-B2FE-4B47-93AC-D544A476A8C1 Q33589182-14F8FF22-0163-463E-851A-0B0317FA82D5 Q33811254-2B67A3B3-606F-42A1-A129-4FB3EC41906C Q33854606-4BB826D6-9E07-44EB-AD36-39BE7B7234A7 Q33866001-B4555CF6-26E6-4EEA-9977-0D0471E7A6BC Q33872837-8087CD3C-25B0-4140-8186-250E9CCE1C47 Q33935153-F32E093A-F8DF-4734-9AFD-078631EF222F Q34048503-03F5D93C-310A-4EE4-B9F4-50E781036B01 Q34545344-FBD3A970-A773-4DC6-8E6D-65C37ABDEB7D Q34619787-11AA6FB6-BD72-4814-B279-7C04B37AC34B Q35013107-AE434E3E-EAFB-4073-A2CE-2A4B9E0D69D5 Q35065235-A531ACE8-53CD-42A2-8189-9BB7FFD8D347 Q35213153-C5CD1059-3925-44A6-BCEF-10BDEC9028C0 Q35486194-B0024EC9-0EE3-4896-AED4-E57D91D56180 Q35529038-28135C84-581C-44F3-AEB9-814614AF26BA Q35575152-2A106D71-9B9F-4348-89B3-B97EA863D877 Q35636430-42DFCD3D-B7A1-4E14-B3B9-6BE1A80A37F8 Q35832054-C33C0746-E36A-4B9B-918C-3761C74E6850 Q36386035-7A4D8DCC-882D-4A8C-9060-1C8803B88669 Q36392027-D3B74EE7-2779-4F44-B8B1-B08881A32FFF Q36782452-FE7F5C90-081D-497C-93A5-FAE2D7ACB08C Q37022223-C17F304A-4EC7-4D90-A13C-3D6E59445986 Q37092305-1001ED05-5773-4B4F-BCEB-FE71D8A97443 Q37283380-C6E8572A-3FE8-433F-923E-4C4B75919534 Q37288916-5CF44848-18A9-4377-B4D2-60F08A8FA809 Q37313694-A8532FA3-8C62-47C4-A159-94A9CC75AD87 Q37649660-3E29A228-637F-400E-B456-81CE4B73E451 Q37728631-B14BA480-37D5-487D-88C0-27DB1E20FCAC Q37976939-3005FE43-E4FF-44AB-B240-A6B1B8ACBFDD Q38355225-D85B4E2D-759B-4D30-89DD-C54A9666DB80 Q38501322-B2F15569-D6EC-4D89-A80F-76654FF7AE6D Q38901830-84133DAB-CC35-4960-99F1-381CE00CBF9D Q39042820-DDD54D27-F842-4313-BD84-697DD4F42B66 Q39166741-2E2BB0D1-3F0F-453E-9CC8-F96D4471C157 Q39171302-BBB2F787-756F-409A-AC4E-EB747AD8A3BB Q39331564-D3B7C051-C15A-4D04-BF59-87AC0970A300 Q39397750-5D84D87A-EA29-4C69-987B-2680BA286866

P2860

NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells.

http://www.wikidata.org/entity/Q43779020

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@en

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@nl

type

label

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@en

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@nl

prefLabel

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@en

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@nl

P1433

Q43779020-EBD7F3E9-1D80-4B87-8C6A-BFC21D6990A3

P1476

Q43779020-11FC761D-148A-442A-BAF7-7EDC70B697A4

P2093

Q43779020-251579E7-33B6-4E09-A010-65925FBE83B9

Q43779020-29412D37-850C-4847-ABE3-EFDBE974DAAD

Q43779020-2B5D534A-401E-421C-B713-9A87E2EE361E

Q43779020-31CA226C-7354-4FF9-8F6C-0AFBEE3311F2

Q43779020-361A9659-4920-4FA1-9450-790F99138B9C

Q43779020-69C964A2-190C-41A3-950A-A2C100A5E3E6

Q43779020-9B2B5756-D482-4ECD-83D0-2CC708476C51

Q43779020-F7C288FE-CA0B-40A6-B1AE-1CA57FB49CF2

P2860

Q43779020-147DCAD9-2E64-4838-97A9-97617EE4FABF

Q43779020-1BB3C374-020C-4BCE-BB89-E0BB53A7269A

Q43779020-24219257-BA66-4A1E-8E18-B5A6D7E31900

Q43779020-2A4F81ED-BC1E-43AC-9F13-1C03B1F6A62E

Q43779020-2B2F2549-2556-4DA4-8519-923DC815F41E

Q43779020-2BDA70E1-6F84-4908-81B5-9ED1B8401A72

Q43779020-4F64D48B-D4B4-4D05-A4B4-BDF8C879151F

Q43779020-50674770-0F6C-4722-8629-21E41E755338

Q43779020-5A9F404B-A7F4-416F-A303-C0AF9EA691FA

Q43779020-5B62A5F9-0391-40ED-8E72-A37494E64E82

P304

Q43779020-4CADC8F5-AFA9-44DC-B2B3-CE520F77786E

P31

Q43779020-157B2CE0-69E3-43B3-B5EE-FDC595DCB67B

P356

Q43779020-8B4BA048-6ED0-41DE-92F0-706BDDF5652E

P407

Q43779020-F0A7C2AD-3E88-4077-8D27-F34D7182CB13

P433

Q43779020-030594E9-8B2A-4BCE-82F0-8988AF701DEC

P478

Q43779020-7F84866E-CFE1-4E94-85B3-764DAF997116

P577

Q43779020-F9C054A1-6BA8-4C38-96C2-3675605DD0AB

P698

Q43779020-39CAEC7F-EC07-4FA2-B932-7FD52F7995EC

P921

Q43779020-A6085B8D-B5C4-463C-A268-7F1DEB93F67B

P356

P1433

Journal of Biological Chemistry

P1476

NF-kappa B activation mediates ...... in N-type neuroblastoma cells.

@en

P2093

Bian X

http://www.w3.org/2001/XMLSchema#string

Castle VP

http://www.w3.org/2001/XMLSchema#string

Feng Z

http://www.w3.org/2001/XMLSchema#string

McAllister-Lucas LM

http://www.w3.org/2001/XMLSchema#string

Opipari AW Jr

http://www.w3.org/2001/XMLSchema#string

Porter AG

http://www.w3.org/2001/XMLSchema#string

Schumacher KR

http://www.w3.org/2001/XMLSchema#string

Shao F

http://www.w3.org/2001/XMLSchema#string

P2860

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

Death receptors: signaling and modulation

Mitochondria and apoptosis

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

DNA topoisomerases

Control of apoptosis by Rel/NF-kappaB transcription factors.

P304

48921-48929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M108674200

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11679590

http://www.w3.org/2001/XMLSchema#string

P921